Selank Dosing & Reconstitution Guide
Dosing Protocol
Route: Intranasal (preferred) or Subcutaneous Frequency: 2–3 times daily (intranasal); once daily (SC) Dose Range: Intranasal: 250–500 mcg per nostril, 2–3x daily; SC: 250–750 mcg daily Cycle Length: 2–4 weeks on, 1–2 weeks off Timing: Morning and afternoon for cognitive effects; avoid evening dosing
Reconstitution
Vial Size: 5mg Water Volume: 5mL Concentration: 1mg/mL
Titration Schedule
Weeks 1–2: 250 mcg 2x daily (intranasal) Weeks 3+: 500 mcg 2–3x daily (intranasal)
Storage
Lyophilized: −20 °C (−4 °F) Reconstituted: 2–8 °C (35.6–46.4 °F) Shelf Life: 28 days
Safety & Contraindications
Safety: Safety is excellent with minimal adverse effects in published studies A peer-reviewed study stated Selank had desirable effects of low-dose benzodiazepines with none of the side effects No dependence potential, no withdrawal effects -- unlike benzodiazepines
Contraindications: Pregnancy and breastfeeding (insufficient data); Hypersensitivity to selank or its components; Concurrent use with MAOI inhibitors without medical supervision